Many STIs can still cause health problems, and testing takes a crucial part in their prevention and treatment, being the only way to know if a person is infected. In the case of HPV, improving women’s adherence to testing programs demonstrated to reduce global cervical cancer incidence and is part of the WHO call to eliminate it by 2030.

Self-collection is valid and acceptable for many STIs. Its flexibility increases participation in cervical cancer screenings in remote or low-resource settings by enabling testing in various locations such as healthcare facilities, workplaces, and homes. Visit our dedicated page to discover our take on self-collection!